QQQ   272.32 (+2.69%)
AAPL   452.03 (+3.32%)
MSFT   209.47 (+2.99%)
FB   260.43 (+1.68%)
GOOGL   1,507.70 (+1.83%)
AMZN   3,158.18 (+2.52%)
NVDA   458.32 (+5.60%)
CGC   17.18 (+1.36%)
BABA   255.63 (+2.90%)
TSLA   1,570.17 (+14.24%)
GE   6.67 (-0.89%)
MU   48.50 (+1.55%)
AMD   82.16 (+6.87%)
T   30.22 (+0.07%)
F   7.11 (-1.66%)
ACB   9.78 (-2.40%)
GILD   68.91 (+1.19%)
NFLX   477.88 (+2.35%)
DIS   131.62 (+0.87%)
BAC   26.81 (-0.41%)
BA   175.28 (-2.69%)
QQQ   272.32 (+2.69%)
AAPL   452.03 (+3.32%)
MSFT   209.47 (+2.99%)
FB   260.43 (+1.68%)
GOOGL   1,507.70 (+1.83%)
AMZN   3,158.18 (+2.52%)
NVDA   458.32 (+5.60%)
CGC   17.18 (+1.36%)
BABA   255.63 (+2.90%)
TSLA   1,570.17 (+14.24%)
GE   6.67 (-0.89%)
MU   48.50 (+1.55%)
AMD   82.16 (+6.87%)
T   30.22 (+0.07%)
F   7.11 (-1.66%)
ACB   9.78 (-2.40%)
GILD   68.91 (+1.19%)
NFLX   477.88 (+2.35%)
DIS   131.62 (+0.87%)
BAC   26.81 (-0.41%)
BA   175.28 (-2.69%)
QQQ   272.32 (+2.69%)
AAPL   452.03 (+3.32%)
MSFT   209.47 (+2.99%)
FB   260.43 (+1.68%)
GOOGL   1,507.70 (+1.83%)
AMZN   3,158.18 (+2.52%)
NVDA   458.32 (+5.60%)
CGC   17.18 (+1.36%)
BABA   255.63 (+2.90%)
TSLA   1,570.17 (+14.24%)
GE   6.67 (-0.89%)
MU   48.50 (+1.55%)
AMD   82.16 (+6.87%)
T   30.22 (+0.07%)
F   7.11 (-1.66%)
ACB   9.78 (-2.40%)
GILD   68.91 (+1.19%)
NFLX   477.88 (+2.35%)
DIS   131.62 (+0.87%)
BAC   26.81 (-0.41%)
BA   175.28 (-2.69%)
QQQ   272.32 (+2.69%)
AAPL   452.03 (+3.32%)
MSFT   209.47 (+2.99%)
FB   260.43 (+1.68%)
GOOGL   1,507.70 (+1.83%)
AMZN   3,158.18 (+2.52%)
NVDA   458.32 (+5.60%)
CGC   17.18 (+1.36%)
BABA   255.63 (+2.90%)
TSLA   1,570.17 (+14.24%)
GE   6.67 (-0.89%)
MU   48.50 (+1.55%)
AMD   82.16 (+6.87%)
T   30.22 (+0.07%)
F   7.11 (-1.66%)
ACB   9.78 (-2.40%)
GILD   68.91 (+1.19%)
NFLX   477.88 (+2.35%)
DIS   131.62 (+0.87%)
BAC   26.81 (-0.41%)
BA   175.28 (-2.69%)
Log in

OTCMKTS:SNWVSANUWAVE Health Stock Price, Forecast & News

$0.25
+0.01 (+3.01 %)
(As of 08/12/2020 02:30 PM ET)
Add
Compare
Today's Range
$0.23
Now: $0.25
$0.26
50-Day Range
$0.24
MA: $0.26
$0.28
52-Week Range
$0.11
Now: $0.25
$0.32
Volume320,949 shs
Average Volume313,053 shs
Market Capitalization$75.47 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.4
SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications worldwide. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.69 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SNWV
CUSIPN/A
CIKN/A
Phone770-419-7525

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.03 million
Book Value($0.03) per share

Profitability

Net Income$-10,430,000.00
Net Margins-1,122.95%

Miscellaneous

Employees14
Market Cap$75.47 million
Next Earnings Date8/20/2020 (Estimated)
OptionableNot Optionable
$0.25
+0.01 (+3.01 %)
(As of 08/12/2020 02:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNWV News and Ratings via Email

Sign-up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions

How has SANUWAVE Health's stock been impacted by COVID-19 (Coronavirus)?

SANUWAVE Health's stock was trading at $0.27 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SNWV stock has decreased by 7.5% and is now trading at $0.2498.
View which stocks have been most impacted by Coronavirus
.

When is SANUWAVE Health's next earnings date?

SANUWAVE Health is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020.
View our earnings forecast for SANUWAVE Health
.

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) issued its quarterly earnings results on Monday, May, 18th. The company reported ($0.01) EPS for the quarter. The company earned $0.15 million during the quarter.
View SANUWAVE Health's earnings history
.

Has SANUWAVE Health been receiving favorable news coverage?

News articles about SNWV stock have been trending negative this week, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. SANUWAVE Health earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.
View the latest news about SANUWAVE Health
.

Are investors shorting SANUWAVE Health?

SANUWAVE Health saw a decrease in short interest in April. As of April 15th, there was short interest totaling 44,000 shares, a decrease of 66.9% from the March 31st total of 132,800 shares. Based on an average daily trading volume, of 922,200 shares, the short-interest ratio is currently 0.0 days.
View SANUWAVE Health's Short Interest
.

Who are some of SANUWAVE Health's key competitors?

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SANUWAVE Health investors own include Ibio (IBIO), Co-Diagnostics (CODX), Sierra Oncology (SRRA), Biocept (BIOC), Tonix Pharmaceuticals (TNXP), Inpixon (INPX), Pharmacyte Biotech (PMCB), Digital Ally (DGLY), Kopin (KOPN) and Achieve Life Sciences (ACHV).

Who are SANUWAVE Health's key executives?

SANUWAVE Health's management team includes the following people:
  • Mr. Kevin A. Richardson II, Chairman & CEO (Age 51)
  • Mr. Shri P. Parikh, Pres (Age 47)
  • Ms. Lisa E. Sundstrom, Chief Financial Officer (Age 50)
  • Mr. Peter Stegagno, Chief Operating Officer (Age 59)
  • Dr. Iulian Cioanta, Chief Science & Technology Officer (Age 56)

What is SANUWAVE Health's stock symbol?

SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."

How do I buy shares of SANUWAVE Health?

Shares of SNWV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SANUWAVE Health's stock price today?

One share of SNWV stock can currently be purchased for approximately $0.25.

How big of a company is SANUWAVE Health?

SANUWAVE Health has a market capitalization of $75.47 million and generates $1.03 million in revenue each year. SANUWAVE Health employs 14 workers across the globe.

What is SANUWAVE Health's official website?

The official website for SANUWAVE Health is www.sanuwave.com.

How can I contact SANUWAVE Health?

SANUWAVE Health's mailing address is 3360 Martin Farm Road Suite 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.